These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8285926)

  • 1. [Synthesis and antigenic activity of peptides from the C-terminal part of the NS4-protein of the hepatitis A virus].
    Semiletov IuA; Firsova TV; Kuzin SN; Khudiakov IuE; Shibnev VA
    Bioorg Khim; 1993 Nov; 19(11):1128-31. PubMed ID: 8285926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis and antigenic activity of peptides from core- and NS3-proteins of hepatitis C virus].
    Semiletov IuA; Firsova TV; Shibnev VA; Viazov SO
    Bioorg Khim; 1993 Jan; 19(1):126-9. PubMed ID: 8387305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic epitopes of the hepatitis A virus polyprotein.
    Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
    Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides.
    Chang JC; Seidel C; Ofenloch B; Jue DL; Fields HA; Khudyakov YE
    Virology; 1999 Apr; 257(1):177-90. PubMed ID: 10208931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies.
    Wienhues U; Ihlenfeldt HG; Seidel C; Schmitt U; Kraas W; Jung G
    Virology; 1998 Jun; 245(2):281-8. PubMed ID: 9636367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
    Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
    J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen.
    Pereboeva LA; Pereboev AV; Wang LF; Morris GE
    J Med Virol; 2000 Feb; 60(2):144-51. PubMed ID: 10596013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of a human monoclonal antibody to the hepatitis C virus NS4 region.
    Mondelli MU; Cerino A; Bellotti V; de Lalla C; Rosa C; Bonelli F; Habets W
    Year Immunol; 1993; 7():220-6. PubMed ID: 8396822
    [No Abstract]   [Full Text] [Related]  

  • 9. Artificial NS4 mosaic antigen of hepatitis C virus.
    Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
    J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders.
    Longombardo G; Ferri C; Marchi S; Costa F; Lombardini F; Vacri L; Bombardieri S; Migliorini P
    Clin Immunol Immunopathol; 1998 May; 87(2):124-9. PubMed ID: 9614926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study of the diagnostic value of peptides, corresponding to various genomic sequences of the hepatitis delta virus].
    Semiletov IuA; Kruglov IV; Karpova VA; Iashina TL; Favorov MO
    Mol Gen Mikrobiol Virusol; 1993; (4):34-7. PubMed ID: 8371725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
    Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
    Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of HCV antigen in the serum by immunodotting].
    Shi HB; Xie L; Huang DZ; He LX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):336-8. PubMed ID: 16643794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human immune response to potential hepatitis C viral epitopes.
    Khanna A; Poduri CD; Murugan P; Kumar S; Sugunan VS; Shenoy KT; Das MR
    Acta Virol; 1998 Jun; 42(3):141-5. PubMed ID: 9842443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides.
    Butkiewicz NJ; Yao N; Wright-Minogue J; Zhang R; Ramanathan L; Lau JY; Hong Z; Dasmahapatra B
    Biochem Biophys Res Commun; 2000 Jan; 267(1):278-82. PubMed ID: 10623610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epitope mapping of antigenic determinants of hepatitis C virus proteins by phage display].
    Rechkina EA; Denisova GF; Masalova OV; Lideman LF; Denisov DA; Lesnova EI; Ataullakhanov RI; Gur'ianova SV; Kushch AA
    Mol Biol (Mosk); 2006; 40(2):357-68. PubMed ID: 16637277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays.
    Prescott LE; Berger A; Pawlotsky JM; Conjeevaram P; Pike I; Simmonds P
    J Med Virol; 1997 Nov; 53(3):237-44. PubMed ID: 9365889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in northern Estonia.
    Tallo T; Lappalainen M; Tefanova V; Priimägi I
    Acta Virol; 2000; 44(3):175-8. PubMed ID: 11155361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.